Viral Vitalism

Source Library

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder

Early randomized clinical trial of semaglutide in adults with alcohol use disorder.

StudyGovernment health research
Source type
Study
Access type
Abstract/index
Publisher
JAMA Psychiatry / PubMed
Indexed by
PubMed
Date
2025
Added
2026-06-19

Trust profile

91

Government health research

Publisher type
Government research
Bias profile
Low

Best used for

  • Research synthesis
  • Public-health context
  • Safety resources

Weak for

  • Primary endpoint extraction when a study is available

Used in Viral Vitalism

Claims supported

  • Early randomized human studies suggest GLP-1 receptor agonists may reduce some alcohol craving or drinking outcomes, but the evidence is not yet sufficient for routine addiction treatment.

Related studies

Related sources

Topic tags

glp-1semaglutidealcohol-use-disorderaddiction

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.